Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Comparison of generic and original imatinib in the treatment of newly diagnosed patients with chronic myelogenous leukemia in chronic phase: a multicenter retrospective clinical study]H Jiang, L T Zhi, M Hou, et al.Zhonghua Nei Ke Za Zhi|January 4, 2022
[Efficacy of total oral regimens containing ixazomib in patients with relapsed and refractory multiple myeloma]J Wang, J J Shang, S Jin, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Long term efficacy of COPADM regimen in the treatment of 20 patients with Burkitt lymphoma]D Yang, P Wang, J Chen, et al.Zhonghua Nei Ke Za Zhi|January 6, 2017
[Clinical analysis in a cohort of 102 patients with myelodysplastic syndrome characterized by erythroid hyperplasia]Y Yu, A N Sun, S N Chen, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 11, 2022
[The prognostic significance of pretransplantation evaluation of IPSS-R and WPSS in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation]C Q Lu, C Hou, P Wang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 23, 2017
[Allogeneic hematopoietic stem cell transplantation for the treatment of acute myeloid leukemia with primary thrombocytosis: three cases report and literatures review]X P Zong, L Tang, J N Cen, et al.Zhonghua Nei Ke Za Zhi|March 6, 2025
[Diagnostic PICALM::MLLT10 fusion by transcriptome sequencing in acute myeloid leukemia and its clinical characteristics]J Xia, X H Hu, Y Zhao, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[A combined regimen based on bortezomib and glucocorticoids for 6 patients with recurrent/refractory immune thrombotic thrombocytopenic purpura]J Yin, H Tian, D Q Kong, et al.Zhonghua Yi Xue Za Zhi|August 17, 2023
[A rational analysis of the commonly used renal tumor scoring systems in predicting surgical outcomes of cystic renal masses]W Chen, Y L Wang, K Cheng, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 24, 2023
[Hsa_circ_0000392 affects the radiation sensitivity of cervical cancer by targeting the miR-145-5p/CRKL/MAPK pathway]J Tian, N Wang, C Wang, et al.Pageof 11